Yoann Pointreau

Le Mans, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 136 publications

Defining physician acceptance of radiosensitivity testing for guiding therapeutic interventions in head and neck cancer: A Delphi consensus study.

Defining physician acceptance of radiosensitivity testing for guiding therapeutic interventions in head and neck cancer: A Delphi consensus study.

Journal: Clinical and translational radiation oncology

Published: January 06, 2026

Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022-01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatin.

Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022-01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatin.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 25, 2025

Organs at risk radiation dose constraints: 2025 update.

Organs at risk radiation dose constraints: 2025 update.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: November 08, 2025

Analysis of treatment practices for locally advanced head and neck squamous cell carcinoma: A survey from GORTEC

Analysis of treatment practices for locally advanced head and neck squamous cell carcinoma: A survey from GORTEC

Journal: Bulletin du cancer

Published: November 03, 2025

Technological innovations in head and neck radiotherapy: What does the future hold?

Technological innovations in head and neck radiotherapy: What does the future hold?

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: August 11, 2025

Specific features of clinical research in radiotherapy in France.

Specific features of clinical research in radiotherapy in France.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: July 21, 2025

Radiotherapy of benign intracranial tumours: 2025 update.

Radiotherapy of benign intracranial tumours: 2025 update.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: June 30, 2025

Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.

Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.

Journal: Lancet (London, England)

Published: June 23, 2025

Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma.

Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma.

Journal: Frontiers in oncology

Published: June 11, 2025

Relationships between oral microbiome and head and neck squamous cell carcinoma: a systematic review.

Relationships between oral microbiome and head and neck squamous cell carcinoma: a systematic review.

Journal: Oral oncology

Published: June 05, 2025

Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study.

Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study.

Journal: International journal of radiation oncology, biology, physics

Published: May 28, 2025

Pushing the Boundaries of Stereotactic Body Radiation Therapy in Irradiated Territories for Nodal Oligorecurrent Prostate Cancer: Outcomes of the CYGNUS Multicentric Retrospective Study.

Pushing the Boundaries of Stereotactic Body Radiation Therapy in Irradiated Territories for Nodal Oligorecurrent Prostate Cancer: Outcomes of the CYGNUS Multicentric Retrospective Study.

Journal: International journal of radiation oncology, biology, physics

Published: May 28, 2025

Showing 1-12 of 136

Last Updated: 09/26/2026